ACE2 and diabetes mellitus: Conversely, RPTC-selective overexpression of catalase or pharmacological blockade of the renin–angiotensin system (RAS) attenuates hypertension, ROS generation, kidney injury and normalised RPTC ACE-2 expression in mouse models of diabetes [21–24].